CVS Health appoints former Elevance Health CFO to board
Get Alerts CVS Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3.3%
Revenue Growth %: +1.2%
Join SI Premium – FREE
CVS Health Corporation (NYSE: CVS) announced that its board of directors elected John E. Gallina to serve as a director, effective March 19, 2026.
Gallina, 66, previously served as executive vice president and chief financial officer of Elevance Health, Inc. (NYSE: ELV) from June 2016 through November 2023. He then worked as executive vice president and advisor to the CEO until his retirement in May 2024.
During his nearly 30-year career at Elevance, Gallina held various finance and audit positions, including chief accounting officer and chief risk officer. Before joining Elevance, he worked as a senior audit manager and certified public accountant at Coopers & Lybrand.
Gallina holds a bachelor's degree in business administration from The Ohio State University.
The appointment was announced in a company statement on March 18, 2026.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Private Credit Fund Caps Redemptions At 5%
- Silvercorp GC Mine mineral resources rise 59% in updated report
- Rocky Mountain Chocolate Factory (RMCF) files $6M mixed shelf
Create E-mail Alert Related Categories
Board Changes, Corporate NewsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share